pyrazines has been researched along with Myositis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Uslu, S | 1 |
| Brown, KJ; Cakir, E; Coley, W; Dillingham, BC; Hathout, Y; Kinder, TB; Nagaraju, K; Rayavarapu, S; Tappeta, K; Van der Meulen, JH | 1 |
2 other study(ies) available for pyrazines and Myositis
| Article | Year |
|---|---|
Myositis due to COVID-19.
Topics: Adult; Amides; Antiviral Agents; C-Reactive Protein; COVID-19; COVID-19 Nucleic Acid Testing; Creatine Kinase; Fibrin Fibrinogen Degradation Products; Glucocorticoids; Humans; Hydroxychloroquine; Lung; Lymphopenia; Magnetic Resonance Imaging; Male; Methylprednisolone; Muscle, Skeletal; Myositis; Pyrazines; SARS-CoV-2; Tomography, X-Ray Computed | 2021 |
Activation of the ubiquitin proteasome pathway in a mouse model of inflammatory myopathy: a potential therapeutic target.
Topics: Animals; Boronic Acids; Bortezomib; Disease Models, Animal; Endoplasmic Reticulum Stress; Mice; Muscle Weakness; Muscle, Skeletal; Myositis; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Pyrazines; Signal Transduction; Ubiquitin; Ubiquitination | 2013 |